10xBio is a dynamic biotechnology brand that focuses on discovering new applications for existing therapies and technologies. By building upon the established safety profiles and known mechanisms of action, 10xBio is able to accelerate the development process and streamline regulatory procedures. The brand offers a range of innovative products, with their most advanced option currently undergoing Phase 2 testing in the field of dermatology.

This product specifically addresses an unmet need in the industry, showcasing 10xBio's commitment to finding solutions to medical challenges. Behind the brand's success is a team of experienced professionals, including Chairman John Dobak, M. D., who has over 25 years of experience in developing medical technologies.

Another key leader is Dan Piacquadio, M. D., who oversees the clinical and regulatory development for 10xBio. Together, they bring a wealth of knowledge and expertise to the brand's endeavors.

Stay up to date with the latest news from 10xBio through their newsroom, where they provide regular updates and press releases. To learn more about the brand and its offerings, or to get in touch, visit their website or connect with them via email or phone